Form 4 for PRCT PROCEPT BioRobotics Corp

Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-06 · accession 0001140361-22-032770 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
I	2022-09-08	2022-09-06	PRCT	CPMG Inc	10%	J - Other	$0.00	-743.0K	10.08M	-7%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-09-06	J	D	743,021	$0.00	10,075,491	I By White Tailed Ptarmigan, LP	—	—	(F2) On September 6, 2022, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 99,881 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13. (F1) CPMG, Inc. is the general partner of White Tailed Ptarmigan, LP and the investment manager of each of Kestrel Fund, L.P. and Mallard Fund, L.P. (together with White Tailed Ptarmigan, LP, the "CPMG Funds"). In such capacities, CPMG, Inc. may be deemed to have voting and investment control over the shares beneficially owned by the CPMG Funds. Antal Desai, a member of the Issuer's board of directors, and Kent McGaughy, Jr., each of whom is a shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Each of Mr. Desai and Mr. McGaughy, Jr. disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein. Antal Desai reports his beneficial ownership of these shares on a separate Form 4.